tiprankstipranks
Advertisement
Advertisement

Innate Pharma Appoints New CEO to Drive Growth

Innate Pharma Appoints New CEO to Drive Growth

Innate Pharma SA (FR:IPH) has released an update.

Claim 55% Off TipRanks

Innate Pharma SA has appointed Jonathan Dickinson as the new CEO and Chairman of the Executive Board, beginning November 1, 2024. Dickinson, who brings extensive biotech and pharmaceutical experience, succeeds interim CEO Hervé Brailly, who will remain in an advisory role to ensure a smooth transition. This leadership change is expected to drive the company’s innovative immuno-oncology pipeline forward, potentially impacting its stock performance.

For further insights into FR:IPH stock, check out TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1